GlaxoSmithKline (GSKN) Q2 2026 Earnings Report
MX:GSKN Q2 2026 EPS Results
- Actual EPS
- MXN 24.94
- Consensus EPS
- MXN 23.04
- Beat/Miss
- Beat by +MXN 1.90
- One Year Ago EPS
- MXN 22.97
MX:GSKN Q2 2026 Revenue Results
- Actual Revenue
- MXN 209.72B
- Expected Revenue
- MXN 204.76B
- Beat/Miss
- Beat by +MXN 4.96B
- YoY Revenue Growth
- +5.87%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/28/2026
- Time
- Before Open
- Conference Call
- Tuesday, July 28, 2026
MX:GSKN Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:GSKN Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GSKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 13.73- | 12.95 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 24.7526.98 | 27.07 | -0.34% (-0.09) | |
| Jul 28, 2026 | 2026 (Q2) | 23.0424.94 | 22.97 | 8.58% (+1.97) | |
| Apr 29, 2026 | 2026 (Q1) | 21.4623.34 | 22.28 | 4.75% (+1.06) | |
| Feb 04, 2026 | 2025 (Q4) | 11.9312.95 | 10.8 | 19.97% (+2.16) | |
| Oct 29, 2025 | 2025 (Q3) | 23.3627.07 | 24.02 | 12.68% (+3.05) | |
| Jul 30, 2025 | 2025 (Q2) | 21.7622.97 | 20.72 | 10.85% (+2.25) | |
| Apr 30, 2025 | 2025 (Q1) | 19.4222.28 | 20.01 | 11.33% (+2.27) | |
| Feb 05, 2025 | 2024 (Q4) | 9.0910.80 | 13.68 | -21.06% (-2.88) | |
| Oct 30, 2024 | 2024 (Q3) | 21.4124.02 | 22.71 | 5.81% (+1.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
